NOTIFICATION OF TRADE AMONG PRIMARY INSIDERS

On 15 January 2010 mandatory notifications of trade among primary insiders of DiaGenic ASA took place. The primary insiders have settled the Total Return equity Swap (TRS) agreements with exposure for 835,000 shares in DiaGenic and subsequently entered into new TRS agreements for 835,000 shares. Net exposure among the insiders is unchanged by these transactions. The transactions are described in more detail below. Håkon Sæterøy, Executive Chairman of the Board of DiaGenic ASA, has through Investor Corporate AS, which is controlled by Sæterøy, settled a Total Return equity Swap agreement (TRS) with exposure of 135,000 underlying shares at a price of NOK 3.24 per share and with expiry date set to 26 January 2010. Subsequently Sæterøy entered into a new TRS agreement with exposure for 135,000 underlying shares and with expiry date set to 25 March 2010, and the TRS price is set to NOK 3.27 per share. After these transactions, Sæterøy directly and indirectly owns a total of 1,396,478 shares, 155,000 warrants (as resolved by the general meeting on 18 December 2009), in addition to the TRS agreement with exposure for 135,000 shares. Director and board member Praveen Sharma has settled a Total Return equity Swap agreement (TRS) with exposure of 700,000 underlying shares at a price of NOK 3.08 per share and with expiry date set to 16 January 2010. Subsequently Sharma entered into a new TRS agreement with exposure for 700,000 underlying shares and with expiry date set to 15 March 2010, and the TRS price is set to NOK 3.11 per share. After the transactions Sharma owns a total of 2,295,000 shares in DiaGenic in addition to the TRS agreement with exposure for 700,000 shares. This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act). Contact: MD PhD Erik Christensen, Managing Director Telephone: +47 95939918 e-mail: erik.christensen@diagenic.com